Hybrigenics hybrigenics.com


Public list: BIO 2016 (619) Pharma Startups (4743) Cancer Therapeutics (1148)

Hybrigenics, based in Paris, France, is engaged in functional proteomics, the study of the role and functions of proteins in cellular pathways. The company is involved in the discovery and validation of targets and is building a pipeline of small molecules, biomarkers, and antibody drug products.

Hybrigenics, based in Paris, France, is engaged in functional proteomics, the study of the role and functions of proteins in cellular pathways. The company is involved in the discovery and validation of targets and is building a pipeline of small mo...Show all

Company (IPO / Went public)

Phone:

Fax:




France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Hybrigenics $7.8M Dec 26, 2007
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Hybrigenics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Integral Molecular

Philadelphia, Pennsylvania, United States
Alive / ActiveIntegral Molecular develops technologies to enable the discovery and development of drugs that target integral membrane proteins, which are involved directly or indirectly in most major diseases, and comprise nearly half of all existing drug targets, including G protein-coupled receptors (GPCRs) and ion channels.Login to see details

Stemina Biomarker Discovery

Madison, Wisconsin, United States
Alive / ActiveStemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the company's metabolomics platform. Metabolomics aims to enable the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progr...Show allLogin to see details
See all 14 competitors